Navigation Links
Watson Confirms Columbia Laboratories' Filing of Definitive Proxy Relating to Watson's Acquisition of U.S. Rights to CRINONE® Progesterone Gel Product Line
Date:6/1/2010

MORRISTOWN, N.J., June 1 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that Columbia Laboratories, Inc. has filed with the Securities and Exchange Commission a definitive proxy seeking Columbia shareholder approval of the previously announced agreement under which Watson would acquire the U.S. rights to Columbia's CRINONE® and PROCHIEVE® product line and 11,200,000 shares of Columbia common stock.  

Additionally, Watson confirmed that it has entered into a $15 million loan agreement with Columbia to support Columbia's ongoing investment in the clinical development of the pre-term birth indication for PROCHIEVE®, as well as other Columbia capital requirements.  If the acquisition transaction with Columbia closes before December 31, 2011, all principal and accrued interest on the loan will be forgiven.

"Filing the proxy represents a significant step towards the closing of our acquisition, which will permit both Watson and Columbia shareholders to begin to realize the value of our proposed partnership," said Paul Bisaro, Watson's President and Chief Executive Officer.  "Our forgivable loan to Columbia demonstrates Watson's commitment to supporting the clinical development activities related to PROCHIEVE's expanded pre-term birth indication and to our collaboration with '/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014 Research and Markets has announced ... report to their offering. Animal vaccines ... Animal vaccines are generally prepared from weakened or dead microbes ... state. Some of the animal vaccines are also formulated using ... or toxic components. These components act as ...
(Date:9/16/2014)... Wash. , Sept. 16, 2014 /PRNewswire/ ... a late stage development company engaged primarily ... medical isotopes for diagnostic and therapeutic applications, ... for technology related to its brachytherapy products.  ... arise from its license from Battelle, under ...
(Date:9/16/2014)... Surgeons at The Children,s Hospital of ... the first successful use of a SynCardia temporary Total ... failing Fontan circulation to bridge him to a heart ... the patient received a Fontan circulation procedure to address ... Fontan operation is the final planned palliative operation for ...
Breaking Medicine Technology:Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 2Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 3Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 2Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 3Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 413-Year-Old Boy with Failed Fontan Circulation Bridged to Transplant Using the SynCardia Total Artificial Heart, Published in Annals of Thoracic Surgery 213-Year-Old Boy with Failed Fontan Circulation Bridged to Transplant Using the SynCardia Total Artificial Heart, Published in Annals of Thoracic Surgery 3
... Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE ... Taylor, one of the Company,s funded researchers, will ... on SNS-01, Senesco,s multiple myeloma drug candidate, at ... Cancer Institute (NCI)-European Organization for Research and Treatment ...
... Nov. 12 Ionian Technologies, Inc. and Roche ... based on Ionian,s rapid isothermal nucleic acid amplification ... applications and customers for the technology and will ... exclusive manufacturing rights for these specific opportunities upon ...
Cached Medicine Technology:Senesco Presents Pre-Clinical Stability and Biological Activity Data on SNS-01 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference 2Senesco Presents Pre-Clinical Stability and Biological Activity Data on SNS-01 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference 3
(Date:9/17/2014)... 17, 2014 Altec Products, Inc., a ... today their Gold Sponsorship of the 2014 Epicor Prophet ... annual conference will take place in Dallas, TX at ... and is organized and hosted by the Epicor Prophet ... comprised of members from more than 900 companies in ...
(Date:9/17/2014)... Experienced dress company, Discount-Dress.com, announces that its ... trendy black bridesmaid dresses. Furthermore, the company has recently ... outfits. Readers can view more about the ... is a famous brand of special occasion gowns and ... as revamped old editions, the supplier has set a ...
(Date:9/17/2014)... CA (PRWEB) September 17, 2014 In a ... San Diego, Dr. William Groff, an expert on the condition ... it. Pearly penile papules , or PPP, is a ... thirties, although other men may be affected as well. The ... the penis. , “While PPP is not a sexually ...
(Date:9/17/2014)... biofilms conjure up images of slippery stones in a ... "bad" biofilms around they even cause pesky dental ... problems a team at the Wyss Institute for ... a robust new platform for designer nanomaterials that could ... textiles, and more. , In short, they want ...
(Date:9/17/2014)... Colo. (PRWEB) September 17, 2014 In ... Sentinel University offers tips to health IT professionals for ... , A recent study by HIMSS shows demand for ... and a candidate’s skill set is the differentiating factor ... that of an IT professional that has clinical workflow ...
Breaking Medicine News(10 mins):Health News:Altec Joins the 2014 Epicor Prophet 21 World Wide User Group Conference as a Gold Sponsor 2Health News:Altec Joins the 2014 Epicor Prophet 21 World Wide User Group Conference as a Gold Sponsor 3Health News:Discount-Dress.com’s Top Designers Are Now Busy Making Its New Black Bridesmaid Dresses 2Health News:New Video Depicts Best Treatment for PPP 2Health News:New Video Depicts Best Treatment for PPP 3Health News:Recruiting bacteria to be technology innovation partners 2Health News:Recruiting bacteria to be technology innovation partners 3Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 3Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 4
... of the nation,s largest Medicaid managed care organizations to implement ... , - The aim of the DailyMed(TM) program is to ... and decrease hospitalizations. , , INDIANAPOLIS, June 24 ... has signed an agreement with Arcadia Resources, Inc. (NYSE Amex: ...
... California to participate in the Foundation,s Orange ... , , NEW YORK, June 24 The Crohn,s & ... six winners from the second annual Celebrating UC Success ... is a program that honors people who have found personal ways ...
... Inc., a developer of innovative therapies in women,s health, ... Coast Service Options, Inc. ("First Coast"), a large regional ... Puerto Rico and the U.S. Virgin Islands, has removed ... incontinence (SUI) from its noncovered services list and will ...
... , EVANSTON, Ill., June 24 SignatureForum, a leading ... its Platinum Physicians List, featuring the highest-rated cosmetic surgeons ... like the Platinum Skin Care Providers group announced last ... of service providers across the United States and Canada. ...
... Many Americans feel that today,s healthcare system is failing ... made it more difficult to afford health insurance. The pivotal ... physical therapist Mitchell Yass, is whether the costs being incurred ... not -- and what healthcare segment seems to be driving ...
... ZixCorp executive offers advice for healthcare businesses to ensure ... Zix Corporation (ZixCorp(R)) (Nasdaq: ZIXI ), ... announced that ZixCorp Vice President and HIPAA subject matter ... amendments to the healthcare privacy and security obligations under ...
Cached Medicine News:Health News:WellPoint State Sponsored Business Launches New Program with Arcadia HealthCare to Help Improve Medication Safety, Efficacy and Compliance for Medicaid Members 2Health News:WellPoint State Sponsored Business Launches New Program with Arcadia HealthCare to Help Improve Medication Safety, Efficacy and Compliance for Medicaid Members 3Health News:WellPoint State Sponsored Business Launches New Program with Arcadia HealthCare to Help Improve Medication Safety, Efficacy and Compliance for Medicaid Members 4Health News:The Crohn's & Colitis Foundation and Procter & Gamble Pharmaceuticals Announce 2009 Celebrating UC Success Contest Winners 2Health News:The Crohn's & Colitis Foundation and Procter & Gamble Pharmaceuticals Announce 2009 Celebrating UC Success Contest Winners 3Health News:The Crohn's & Colitis Foundation and Procter & Gamble Pharmaceuticals Announce 2009 Celebrating UC Success Contest Winners 4Health News:The Crohn's & Colitis Foundation and Procter & Gamble Pharmaceuticals Announce 2009 Celebrating UC Success Contest Winners 5Health News:First Coast Medicare to Provide Case by Case Reimbursement for the Renessa(R) Treatment for Incontinence in Women 2Health News:First Coast Medicare to Provide Case by Case Reimbursement for the Renessa(R) Treatment for Incontinence in Women 3Health News:SignatureForum Reveals Top-Rated Cosmetic Surgeons in US 2Health News:One Man's Mission to Improve Our Healthcare System and Resolve Chronic Pain 2Health News:Zix Corporation Addresses New HIPAA Regulations 2Health News:Zix Corporation Addresses New HIPAA Regulations 3
For the direct colorimetric determination of Urea Nitrogen (BUN) in human serum or plasma....
... Intended for the quantitative ... serum. Reaction: kinetic, lag phase ... followed by linear phase of ... 340 nm. Linearity: 120 mg/dL ...
For the quantitative determination of Urea Nitrogen in serum. Linearity: 80 mg/dl. Reaction measured at 340 nm....
For the quantitative determination of direct bilirubin in human serum. Linearity: 20 mg/dl...
Medicine Products: